首页> 外文期刊>International journal of immunogenetics >Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.
【24h】

Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.

机译:KIR 2DL2和HLA-C1(Asn 80)的组合可提高拉脱维亚人对1型糖尿病的敏感性。

获取原文
获取原文并翻译 | 示例
       

摘要

Killer immunoglobulin-like receptors (KIRs) are known to modulate natural killer (NK) and NK T-cell function by interacting with human leucocyte antigen (HLA) class I ligands on target cells. The aim of our study was to investigate the influence of KIR2D genes with their HLA-C ligands in susceptibility to type 1 diabetes. A total of 98 type 1 diabetes patients and 70 healthy subjects from Latvia were typed for KIR genes and HLA-C ligands using polymerase chain reaction-based genotyping. The HLA C1+/C2+ combination was positively, and C1-/C2+ combination was negatively, associated with type 1 diabetes. Stratification analysis of KIR/HLA-C ligand combinations showed 2DL2+/C1+, 2DL3+/C1+, and 2DS2+ /C1+ to be positively, and 2DL2-/C1- and 2DS2-/ C1- to be negatively, associated. The presence of 2DL2-HLA-C1 in the absence of 2DS1, 2DS2 confers maximum susceptibility. Absence of 2DL2 and HLA-C1 along with absence of 2DS1 and 2DS2 confer maximum protection. A hypothetical model of KIR/ligand combinations on immune responses and type 1 diabetes susceptibility is proposed. Our results suggest that a combination KIR2DL2- HLA-C1 plays a critical role in susceptibility or protection in Latvians against type 1 diabetes.
机译:已知杀伤免疫球蛋白样受体(KIR)通过与靶细胞上的人白细胞抗原(HLA)I类配体相互作用来调节自然杀伤(NK)和NK T细胞功能。我们研究的目的是研究KIR2D基因及其HLA-C配体对1型糖尿病易感性的影响。使用基于聚合酶链反应的基因分型方法,对来自拉脱维亚的98位1型糖尿病患者和70位健康受试者的KIR基因和HLA-C配体进行了分型。 HLA C1 + / C2 +组合呈阳性,而C1- / C2 +组合呈阴性,与1型糖尿病相关。 KIR / HLA-C配体组合的分层分析显示2DL2 + / C1 +,2DL3 + / C1 +和2DS2 + / C1 +呈正相关,而2DL2- / C1-和2DS2- / C1-呈负相关。在没有2DS1、2DS2的情况下2DL2-HLA-C1的存在赋予了最大的敏感性。缺少2DL2和HLA-C1以及缺少2DS1和2DS2可以提供最大的保护。提出了KIR /配体组合对免疫应答和1型糖尿病易感性的假设模型。我们的结果表明,组合KIR2DL2- HLA-C1在拉脱维亚人群1型糖尿病的易感性或保护中起着关键作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号